Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 2351 to 2400 of 2529

TitleReference numberPublishedLast updated
Transcutaneous electrical stimulation of the trigeminal nerve for ADHDHTG653
Transcutaneous microwave ablation for severe primary axillary hyperhidrosisHTG458
Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adultsHTG493
Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraineHTG408
Transient loss of consciousness ('blackouts') in over 16sCG109
Transient loss of consciousness ('blackouts') in over 16sQS71
Transilluminated powered phlebectomy for varicose veinsHTG16
Transition between inpatient hospital settings and community or care home settings for adults with social care needsNG27
Transition between inpatient hospital settings and community or care home settings for adults with social care needsQS136
Transition between inpatient mental health settings and community or care home settingsNG53
Transition between inpatient mental health settings and community or care home settingsQS159
Transition from children's to adults' servicesQS140
Transition from children's to adults' services for young people using health or social care servicesNG43
Translaryngeal tracheostomyHTG317
Transmyocardial laser revascularisation for refractory angina pectorisHTG192
Transoral carbon dioxide laser surgery for primary treatment of oropharyngeal malignancyHTG337
Transperineal biopsy for diagnosing prostate cancerHTG680
Transperineal laser ablation for treating lower urinary tract symptoms of benign prostatic hyperplasiaHTG737
Transperineal template biopsy and mapping of the prostateHTG237
Transpupillary thermotherapy for age-related macular degenerationHTG31
Transurethral electrovaporisation of the prostateHTG4
Transurethral laser ablation for recurrent non-muscle-invasive bladder cancerHTG522
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasiaHTG482
Transurethral water-jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasiaHTG691
Transvaginal laser therapy for stress urinary incontinenceHTG581
Transvaginal laser therapy for urogenital atrophyHTG582
Transvaginal mesh repair of anterior or posterior vaginal wall prolapseHTG456
Transvenous obliteration for gastric varicesHTG658
Trastuzumab deruxtecan for treating HER2-low metastatic or unresectable breast cancer after chemotherapyTA992
Trastuzumab deruxtecan for treating HER2-mutated advanced non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)TA976
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatmentsTA862
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapiesTA704
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction cancer after anti-HER2 treatment (terminated appraisal)TA879
Trastuzumab deruxtecan for treating hormone receptor-positive HER2-low metastatic breast cancer after 2 or more endocrine treatments (terminated appraisal)TA1112
Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancerTA632
Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxaneTA458
Trastuzumab for the treatment of HER2-positive metastatic gastric cancerTA208
TraumaQS166
Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal)TA945
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplantTA640
Trifluridine–tipiracil for previously treated metastatic colorectal cancerTA405
Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatmentsTA852
Trifluridine–tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatmentsTA1008
trublood-prostate for triaging and diagnosing people with prostate cancer symptomsMIB268
TuberculosisNG33
TuberculosisQS141
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisationMIB210
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancerHTG719
Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosisHTG648

Results per page

  1. 10
  2. 25
  3. 50
  4. All